Montelukast Sodium
Product Images NDC 66116-503

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 66116-503). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medvantx, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Change In Height (cm) From Randomization Visit By Scheduled Week (treatment Group Mean ± Standard Error Of The Mean) (B24549cf 6c14 4e49 8756 5bd6d88ec6b8 01)

A line graph showing change in height (cm) over weeks on treatment for Montelukast Sodium 5 mg, Beclomethasone 336 mcg, and placebo groups. The x-axis represents weeks on treatment from -19 to 56, and the y-axis represents change in height from -3 to 7 cm. Data points show a general increase in height over time for all groups with slight variations.*

FDA Label Image

Montelukast Sodium Structural Formula (B24549cf 6c14 4e49 8756 5bd6d88ec6b8 02)

Chemical structure of Montelukast Sodium, showing its molecular composition and bonding arrangement.*

FDA Label Image

Figure 2: Fev1 Mean Percent Change From Baseline (u.s. Trial: Montelukast Sodium N = 406; Placebo N = 270) (anova Model) (B24549cf 6c14 4e49 8756 5bd6d88ec6b8 03)

A line graph depicting mean percent change from baseline over weeks in treatment for Montelukast Sodium versus placebo. The x-axis shows weeks (0 to 15), and the y-axis shows mean percent change. Montelukast Sodium data is marked with solid circles and shows a higher increase compared to placebo, marked with open squares. Error bars are included, and a washout period is indicated after week 12.*

FDA Label Image

Montelukast Sodium Tablets 10mg #30 (B24549cf 6c14 4e49 8756 5bd6d88ec6b8 04)

Montelukast Sodium Tablets 10 mg, 30 tablets, from MedStart CONNECT by MedVantx, Inc. The label includes dosage instructions, storage conditions (20-25°C), and notes it is for prescription use only. Distributed by MedVantx, Inc., San Diego, CA, with manufacturing by Teva Pharmaceuticals USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.